| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/30/2014 | CN101724075B Remodeling and glycoconjugation of peptides |
| 04/30/2014 | CN101360826B Anti-alpha2 integrin antibodies and their uses |
| 04/29/2014 | US8710205 Transcription factor |
| 04/29/2014 | US8710202 Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity |
| 04/29/2014 | US8710196 Protein purification |
| 04/29/2014 | US8710189 Anti-FGFR3 antibodies and methods using same |
| 04/29/2014 | US8710025 Modified and stabilized GDF propeptides and uses thereof |
| 04/29/2014 | US8710015 Tropoelastin derivatives |
| 04/29/2014 | US8710004 Stable liquid VEGF antagonist formulations |
| 04/29/2014 | US8709778 Method of adenoviral vector synthesis |
| 04/29/2014 | US8709773 DFPase enzymes from Aplysia californica |
| 04/29/2014 | US8709772 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| 04/29/2014 | US8709760 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 04/29/2014 | US8709759 Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins |
| 04/29/2014 | US8709758 Methods and compositions for inhibition of neutrophil exocytosis |
| 04/29/2014 | US8709757 Method for producing interferon alpha 5 |
| 04/29/2014 | US8709756 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 04/29/2014 | US8709755 Mirac proteins |
| 04/29/2014 | US8709754 Recombinant vectors for use in position-independent transgene expression within chromatin |
| 04/29/2014 | US8709752 Process for producing dipeptides or dipeptide derivatives |
| 04/29/2014 | US8709710 Methods of modulating interleukin-22 and immune response by notch regulators |
| 04/29/2014 | US8709441 TC-83-derived alphavirus vectors, particles and methods |
| 04/29/2014 | US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 04/29/2014 | US8709430 Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids |
| 04/29/2014 | US8709427 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form |
| 04/29/2014 | US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/29/2014 | US8709425 Antibodies to non-functional P2X7 receptor |
| 04/29/2014 | US8709424 Anti-GITR antibodies |
| 04/29/2014 | US8709405 Cancer vaccines containing epitopes of oncofetal antigen |
| 04/29/2014 | CA2813435C Synthesis of sialic acid in plants |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/24/2014 | WO2014062535A1 Mammalian cell culture processes for protein production |
| 04/24/2014 | WO2014061783A1 Human antibody specific to toxin produced from clostridium difficile, or antigen-binding fragment thereof |
| 04/24/2014 | WO2014059502A1 Method using penicillium echinulatum filamentous fungus for producing enzymes for use in enzymatic hydrolysis of lignocellulosic biomass |
| 04/24/2014 | WO2014035693A3 Methods and compositions related to modulators of eukaryotic cells |
| 04/24/2014 | WO2014011993A3 Epitope spreading associated with car t-cells |
| 04/24/2014 | WO2013188305A3 Fungal beta-xylosidase variants |
| 04/24/2014 | WO2013114367A9 C10rf32 antibodies, and uses thereof for treatment of cancer |
| 04/24/2014 | WO2012125626A3 Decorin compositions and use thereof |
| 04/24/2014 | WO2012112690A3 Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains |
| 04/24/2014 | US20140113861 Cartilage product |
| 04/24/2014 | US20140113331 Systems and Methods for Cultivating, Harvesting and Processing Biomass |
| 04/24/2014 | CA2874979A1 Antigen binding proteins that bind dll-4 |
| 04/23/2014 | EP2722343A1 ANTI-erbB3 ANTIBODY |
| 04/23/2014 | EP2722055A1 Combination therapy with antibodies and anti-VEGF agents for the treatment of cancer |
| 04/23/2014 | EP2721072A1 Reagents and methods for bispecific antibody-based binding of target molecules |
| 04/23/2014 | EP2721051A1 A method for the production of hydrolyzed allergens |
| 04/23/2014 | CN103748222A Novel anti-human NGF antibody |
| 04/23/2014 | CN103748220A Bacteriocin derived from lactobacillus rhamnosus |
| 04/23/2014 | CN103748113A Modulators of plexin b2 activity |
| 04/23/2014 | CN103748105A A method for the production of hydrolyzed allergens |
| 04/23/2014 | CN103740797A Method for preparing high-hydrolysis degree functional oligopeptide by use of high-temperature peanut meal |
| 04/23/2014 | CN103740796A Method for extracting polypeptides from skimmed protein milk supernatant |
| 04/23/2014 | CN103740795A Method for extracting and preparing high-quality collagen from holothuria fuscogilva |
| 04/23/2014 | CN103740794A Technology method for preparing active components of chlorella through scale classification |
| 04/23/2014 | CN103740793A Method for producing fish skin collagen |
| 04/23/2014 | CN103740792A Preparation method of Sinonovacula constricta polypeptide with antioxidation function and application thereof |
| 04/23/2014 | CN103740791A Method for extracting collagen powder from deep sea cod skin |
| 04/23/2014 | CN103740786A Method for preparing potato extract powder by utilizing potato starch wastewater |
| 04/23/2014 | CN103740754A Mouse nerve growth factor-containing expression vector and cell |
| 04/23/2014 | CN103739712A Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life |
| 04/23/2014 | CN103739711A High affinity human antibodies to human ill-4 receptor |
| 04/23/2014 | CN103739704A Testudinate collagen and extraction method thereof |
| 04/23/2014 | CN103739693A Pinctada martensii meat antioxidant peptide sequence with antioxidant activity and application of Pinctada martensii meat antioxidant peptide sequence |
| 04/23/2014 | CN103739683A Insecticidal protein, and encoding gene and use thereof |
| 04/23/2014 | CN102732468B Enterococcus faecalis and broad-spectrum bacterium inhibition function thereof |
| 04/23/2014 | CN102504019B Method for separating cecropin antimicrobial peptides |
| 04/23/2014 | CN102352337B Recombinant bacteria expressed by escherichia coli genome N-acetylase by control of heterogenous promoter, and use thereof |
| 04/22/2014 | US8703926 Modified lecithin-cholesterol acyltransferase enzymes |
| 04/22/2014 | US8703920 Fully human antibodies against N-cadherin |
| 04/22/2014 | US8703918 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof |
| 04/22/2014 | US8703915 Mutant proteins and methods for producing them |
| 04/22/2014 | US8703914 Heterologous expression of neisserial proteins |
| 04/22/2014 | US8703908 Expression and export of angiogenesis inhibitors as immunofusins |
| 04/22/2014 | US8703905 Endoplasmic reticulum localization signals |
| 04/22/2014 | US8703733 Humanized TTC and methods of use thereof |
| 04/22/2014 | US8703471 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 04/22/2014 | US8703459 Catalytic domains of beta(1,4)-galactosyltransferase I having altered metal ion specificity |
| 04/22/2014 | US8703443 γ-L-PGA producing microorganism, method of producing γ-L-PGA using the microorganism, crosslinked substance produced using the microorganism, and external dermal agent produced using the microorganism |
| 04/22/2014 | US8703141 Method for treating Crohn's disease by administering an anti-IL-12 antibody |
| 04/22/2014 | US8703140 Inhibition of factor B, the alternative complement pathway and methods related thereto |
| 04/22/2014 | US8703135 Biological materials related to c-Met |
| 04/22/2014 | US8703133 Antibody variants |
| 04/22/2014 | US8703131 Nanobodies against tumor necrosis factor-alpha |
| 04/22/2014 | US8703127 Methods and materials for the diagnosis of prostate cancers |
| 04/22/2014 | CA2751655C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 04/22/2014 | CA2658677C Novel bacillus thuringiensis gene with lepidopteran activity |
| 04/22/2014 | CA2589937C Rhamnose promoter expression system |
| 04/22/2014 | CA2580620C Method of detecting hepatitis b virus s antigen |
| 04/22/2014 | CA2548135C Synthetic hla binding peptide analogues and uses thereof |
| 04/22/2014 | CA2507817C Il-21 production in prokaryotic hosts |
| 04/22/2014 | CA2507307C Increased production of secg protein in bacillus subtilis |
| 04/22/2014 | CA2398998C Cd40-binding apc-activating molecules |
| 04/17/2014 | WO2014058025A1 Method of establishing modified host cell |
| 04/17/2014 | WO2014057437A2 Method for preparing c1q recombinant protein |
| 04/17/2014 | WO2014056199A1 Production and purification methods of polypeptide |
| 04/17/2014 | WO2014005103A3 Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture |
| 04/17/2014 | WO2013191146A9 Kit for diagnosing malignant melanoma |
| 04/17/2014 | WO2013109279A3 Stabilization of the anti-cd20 antibody rituximab |
| 04/17/2014 | WO2012109220A3 Cell cycle control for improving process performance and recombinant expression in fungal host cells |